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Abstract
Background: The Urabe AM9 vaccine strain of mumps virus contains two variants of V protein: VWT (of HN-A1081
viral population) and VGly (of HN-G1081). The V protein is a promoting factor of viral replication by blocking the
IFN antiviral pathway.
Findings: We studied the relationship between V protein variants and IFN-a2b-induced apoptosis. V proteins
decrease activation of the extrinsic IFN-a2b-induced apoptotic pathway monitored by the caspase 8 activity, being
the effect greater with the VWT protein. Both V proteins decrease the activity of caspase 9 of the intrinsic
apoptotic pathway. In a system without IFN, the VWT and VGly proteins expression promotes activation of caspases
3 and 7. However, when the cellular system was stimulated with IFN-a, this activity decreased partially. TUNEL
assay shows that for treatment with IFN-a and ibuprofen of cervical adenocarcinoma cells there is nuclear DNA
fragmentation but the V protein expression reduces this process.
Conclusions: The reduction in the levels of caspases and DNA fragmentation, suggesting that V protein,
particularly VWT protein of Urabe AM9 vaccine strain, modulates apoptosis. In addition, the VWT protein shows a
protective role for cell proliferation in the presence of antiproliferative signals.
Findings
The IFN type-I pathway is the major cellular mechanism
of the antiviral response. The effect is the induction of
gene expression to blocking the viral infection. The effi-
cient antiviral cellular response promotes the develop-
ment of viral strategies to antagonize the effect of IFN
[1-4]. In the paramyxoviruses, inhibition of IFN type-I
response occurs due to the activity of the nonstructural
V protein [5,6]. Activation of the JAK-STAT pathway by
IFN simultaneously activates others processes regulated
by IFN such as apoptosis, a physiological process where
cells undergo morphological changes, activation of pro-
teases, nuclear DNA fragmentation and cell death [1,2].
The central component of the apoptotic machinery is a
proteolytic system consisting of the family of cysteine
proteases (caspases) [7-9]. Apoptosis can be initiated
and executed through many different pathways, which
can be categorized into two main groups: extrinsic and
intrinsic [8,9]. Sequential activation of a caspase by
another creates an expansive cascade of proteolytic
activity that produces digestion of structural proteins in
the cytoplasm, DNA degradation and phagocytosis of
apoptotic bodies [10]. Because apoptotic cells are rapidly
phagocytosed, apoptosis promotes development of an
efficient immune response against viral antigens [11].
Many viruses have evolved mechanisms to avoid or at
least to control apoptosis [12]. One of the mechanisms
of pathogenicity of mumps virus is V protein expression
required to blocking the expression of viral genes acti-
vated by IFN through cytoplasmic interaction with the
STAT1-STAT2 heterodimer [13,14]. What cellular pro-
cess is the prime target to promote viral replication?
Effects of the inactivation of the IFN pathway on apop-
tosis, in particular, are not known in detail. IFN-a
induces apoptosis and stimulates the activity of caspases
1, 2, 3, 8 and 9 and promotes the extrinsic apoptotic
pathway and the activation of caspase 8 as the initiator
of the caspase cascade to execute apoptosis [15].
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the HN-A1081 population, neurovirulence associated)
and VGly (from the HN-G1081 population) proteins of
the Urabe AM9 strain vaccine of mumps virus [16-18],
in order to determine whether, as the simian virus 5 V
protein [19] and the C protein parainfluenza virus type I
(HPIV-1) [20], they have the capacity of blocking IFN-
a-induced apoptosis. VWT and VGly of the Urabe AM9
strain were expressed in cervical adenocarcinoma cells
to analyze its effect on the activity of initiator and effec-
tor caspases. The cells were transfected with 10 μgo f
vector DNA (pCDNA4/His/Max-VA and VG) and Tur-
boFect transfection reagent (Fermentas, Glen Burnie,
MD, USA). 36 h after transfection, the cells were treated
with 4000 IU/mL of IFN-a2b (Urifrón, Probiomed,
Mexico) and 40 μM of MG-132 (Sigma, St. Louis, MO,
USA). The activity of caspases 3, 7 and 8 was evaluated
with the Caspase-Glo 3/7 kit and Caspase-Glo 8 kit
(Promega, Madison, WI, USA) using the substrate Ac-
DEVD-pNA for caspase 3/7 or a C-LETD-pNA for cas-
pase 8 and incubated for 60 min at room temperature.
The activity of caspases 3, 7 and 8 was measured by a
GloMax 20/20 luminometer (Promega, Madison, WI,
USA). The activity of caspase 9 was measured with the
Caspase 9 Colorimetric Assay Kit (Biovision) using
LEDH-pNA as substrate by absorbance at 420 nm, 2 h
after adding substrate.
This study starts with the analysis of the effect of V
proteins on caspase 8 activity. In the system without
IFN-a, low activity of caspase 8 was detected, although
expression of VGly increases the activity in 113% (Figure
1A). Instead, the treatment of the system with IFN-a2b
promotes an increase of 2400% of the enzymatic activity
in control cells, which decreases in those that express
VWT and VGly in 73% and 38%, respectively. The
decrease was greater with the VWT protein. The same
activity pattern was recorded in cells stimulated with
IFN-a2b and with the MG132 proteasome inhibitor. In
control cells the activity increased by 224%, whereas
that of VWT and VGly increased by only 96% and
113%, respectively, without significant difference in the
decrease of caspase 8 activity (Figure 1A). We can con-
clude the VWT protein of Urabe AM9 strain has a
greater inhibitory effect on the activity, i.e., the protein
derived from the HN-A1081 population associated with
neurovirulence may modulate the extension in the acti-
vation of the extrinsic apoptotic pathway.
On the other hand, cytoplasmic replication of mumps
virus produces dsRNA molecules that may activate the
intrinsic apoptotic pathway by intracellular stress and
the V proteins of mumps virus may have an effect on
apoptosis that involves the intrinsic or mitochondrial
pathway. In the system without IFN-a2b treatment, it
was demonstrated that the enzyme activity increased
51% in cells that express the VWT and 8% in cells with
VGly (Figure 1B). Treatment of the C33 cell line with
IFN-a2b activates the mitochondrial apoptotic pathway
detected by an increase of 107% in caspase 9 activity. In
contrast, in the IFN-treated cells that express VWT and
VGly proteins, the activity of caspase 9 decreased 35%
and 38%, respectively (Figure 1B), suggesting the activa-
tion of the apoptotic mitochondrial pathway, which may
be reduced by expression of V proteins of the mumps
virus regulating the magnitude of apoptosis. Although
data are obtained for detection of caspase 9, a high acti-
vation is not observed as with caspase 8. If there is
strong activation of the intrinsic apoptotic pathway by
another factor of mumps virus in combination with the
V protein, this must be analyzed in further studies.
Caspases 8 and 9 are directly responsible for activation
of the effector caspases 3 and 7. Their activity was ana-
lyzed in cells non-transfected and without stimulation
with IFN-a2b, where we found that there is a low level
of enzymatic activation probably due to the introduction
of DNA plasmid (pCDNA4/HisMaX), whereas in cells
that express VWT and VGly proteins there is an
increase in the activity of caspase 3 and 7 of 457% and
526%, respectively (Figure 1C). When the system was
stimulated with IFN-a2b, the activity of caspases 3 and
7 increased 77%, 91% y 76% in control cells, and with
the VWT and VGly proteins, respectively, compared
with to the system without treatment. A detailed com-
parison of caspases 3 and 7 activity with or without IFN
shows that V proteins partially inhibit the activity,
although there was no statistically significant difference
on enzymatic activity in both proteins. These data sug-
gest a partial inhibitory activity of 61% and 49%, respec-
tively, on the IFN-a-induced apoptosis by the VWT and
VGly proteins of mumps virus (Figure 1C). Despite acti-
vation of the IFN pathway, activity of caspases 3 and 7
decreased compared to cells that did not express the
viral protein, suggesting a role for the V protein in the
disruption of the antiviral response controlling the
apoptosis. However, V proteins of Urabe AM9 vaccine
strain did not completely inhibit caspase activity in our
study and, therefore, the apoptosis. Despite the partial
inhibition of caspases 8, 3 and 7, the reported residual
activity suggests that nuclear DNA fragmentation, a key
process in apoptosis, should be carried out.
To determine the effect of V proteins on nuclear DNA
fragmentation, TUNEL colo r i m e t r i ca s s a y( T e r m i n a l
deoxynucleotidyl transferase Biotin-dUTP Nick End
Labeling) was performed in cells expressing the V pro-
teins, which were treated with IFN-a. In cells positive
for apoptosis, nuclei are stained brown. Color RGB-type
images were obtained using a Nikon microscope (Nikon
Inc., Mel, NY) coupled to a Cyber-Shot DSC-W55
(Sony). The images were processed using the ImageJ
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Figure 1 Activity of caspase 8, caspase 9 and caspase 3/7 in the cervical carcinoma cell line expressing VWT and VGly proteins of
mumps virus. (A) Caspase 8 measured with the Caspase-Glo 8 assay (Promega) using Ac-LETD-pNA as substrate. *, statistical difference between
samples treated with IFN and IFN/MG132 with respect to untreated group. §, statistical difference between samples with and without treatment
with IFN and IFN/MG132. ℓ, statistical difference between samples with VWT and VGly. (B) Caspase-9 measured with the colorimetric assay
Caspase 9 (BioVision) using LEDH-pNA as substrate. The absorbance was taken at 420 nm in a Shimadzu spectrophotometer 2 h after adding
substrate. (C) Caspase 3 and 7 measured with the Caspase-Glo 3/7 assay system (Promega) using the substrate Ac-DEVD-pNA. Readings were
taken 1 h after in the GloMax 20/20 luminometer (Promega). Each column represents the mean ± SD of three independent experiments. (In B
and C, * represents the statistical difference between samples with and without IFN). Student t-test (P < 0.05).
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Page 3 of 7program (NIH) through its conversion to the type-8 bit
and the Analyze Particles tool with a size of 248 × 201
pixels, and circularity of 0.5-1.0, excluding the edges. In
cells without transfection and IFN treatment, the rate of
apoptotic cells was <3%, whereas there was 20% of DNA
fragmentation in cells that express the VWT protein
and without change with the VGly protein. In cells trea-
ted with IFN-a there were TUNEL-positive cells. How-
ever, in those cells that express VWT and VGly, DNA
fragmentation decreased 85% and 87%, respectively (Fig-
ure 2). Despite inhibition observed on nuclear DNA
fragmentation by the V proteins of mumps virus in cells
treated with IFN, it was necessary to show that with a
strong activation of apoptosis such protein could regu-
late the extent of DNA digestion. The system was trea-
ted with ibuprofen (50 μg/mL) for 12 h and then
subjected to TUNEL assay. Ibuprofen is a nonsteroidal
anti-inflammatory drug that promotes mitochondrial
damage by the modification of oxidative phosphoryla-
tion, inhibition of ATP production, modification of per-
meability of inner membrane and opening of
mitochondrial permeability transitory pore, and axis of
triggering an apoptotic signal [21]. In non-transfected
cells of cervical adenocarcinoma, treatment with the
compound produced 95-98% of TUNEL-positive cells;
however, with expression of VWT and VGly, the num-
ber of positive cells was reduced 79% and 74%, respec-
tively. Comparison between cells expressing the V
protein showed that nuclear DNA fragmentation is
higher in cells with VWT (Figure 2). Our data suggest
that V protein of Urabe AM9 may be a protective or
modulating factor for apoptosis, as shown for V protein
of SV5 and C protein of Sendai virus [19,22]. Moreover,
it was interesting to observe that stimulation with IFN-
a activates the caspases in our study and that the V pro-
teins of mumps virus decrease its activation. However,
although V protein expression promotes activation of
the studied caspases, there is induction of apoptosis and,
simultaneously, antiapoptotic activity is present when
the cellular system was stimulated with IFN-a.T h i sh a s
been observed with other viruses that cause both apop-
totic and anti-apoptotic effects through several viral pro-
teins with the aim of regulating the timing of apoptosis,
after viral replication but before activation of antiviral
defense systems. Such is the case of the V protein of
measles virus that inhibits the p73 protein involved in
the regulation of apoptosis [23], whereas its protein C
interferes with the induction of apoptosis by blocking
PKR. With this virus, pro- and anti-apoptotic events
occur simultaneously [24]. We should mention that the
usual activities of the pro- and anti-apoptotic protein V
could be the result of two opposing activities between V
and I proteins of mumps virus as with the V and C pro-
teins of Sendai virus. It is likely that the apoptosis
inhibitory activity resides in protein V, whereas the pro-
cess-inducing activity resides in I protein, a fact that is
being studied by our group.
Activation of type-I IFN activates other signal trans-
duction pathways such as the MAPK pathway that regu-
lates several IFN-initiated processes as apoptosis and cell
proliferation. A key enzyme in both processes is p38
MAPK that mediates the growth-suppressive effect of
type-I IFN, stress signals, inflammatory response that
induce apoptosis and is regulated by ERK1/2 [25,26]
related to cell proliferation. The MAPK pathway may be
a target of mumps virus to control IFN-a-induced apop-
tosis and regulate cell proliferation. To assess this, we
studied the effect of V proteins on proliferation under
conditions of antiproliferative stimulus. Determination of
cell proliferation was performed with the CellTiter 96
Aqueous One Solution Cell Proliferation Assay (Pro-
mega, Madison, WI, USA) in cells treated with IFN-a2b,
MG132 and PD98059 (2’-amino-3’-methoxyflavone, a
selective inhibitor of MAP kinase kinase 1 and 2 (MEK1/
2), enzymes responsible for activating ERK1/2. The quan-
tity of MTS bioreduced to formazan in the assay is mea-
sured spectrophotometrically at 490 nm and is directly
proportional to the number of living cells in culture. In
cells expressing V proteins without chemical stimulus,
cell proliferation is not affected (Figure 3). Activation of
the IFN pathway by IFN-a2b shows that, in control cells
and those cells that express VGly, cell proliferation is
decreased 19% and 26%, respectively, in regard to the sys-
tem without treatment. However, cells with the VWT
protein are not affected. The combination of IFN-a2b
and MG132 decreases proliferation of the C33 cell line,
with or without V proteins, between 14% and 20%,
respectively. When PD98059 was used (conditions of
non-proliferation) without activating the IFN pathway we
did not observe the affectation in cell proliferation with
those cells expressing V proteins. Under conditions of
three treatments with IFN-a, MG132 and PD98059, it
was shown that proliferation decreased only in cells
expressing the VGly protein (Figure 3). The VWT pro-
tein appears to be potentially protective against apoptotic
stimuli such as anti-proliferative IFN-a2b and IFN-a2b,
MG132 and PD98059.
Finally, our data provide evidence with regard to the
VWT protein of the Urabe AM9 vaccine strain of
mumps virus, which seems to exert a best modulatory
role on apoptosis and cell proliferation with regard to
t h eV G l yp r o t e i n .T h i ss u g g e s t st h a t ,i nv i r a lp a t h o g e n -
esis, the regulation of apoptosis potentially mediates the
damage. The detailed mechanism for the implementa-
tion of such activity should be studied in a future inves-
tigation. Information of the identity of caspases induced
or inhibited by some factor in the mumps virus infec-
tion is important in order to establish the molecular
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Figure 2 Apoptosis in cervical adenocarcinoma cells that express proteins VWT and VGly. At 48 h of expression, 2 h with 4000 IU/mL of
IFN-a. The DeadEnd Colorimetric TUNEL System marks the fragmented DNA in situ with biotinylated nucleotides by terminal transferase rTdT.
The complex was detected with streptavidin-horseradish peroxidase (HRP) using the chromogen substrate diaminobenzidine and H2O2. As a
result of the procedure the nuclei are stained dark brown.
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Page 5 of 7mechanism of the virus in the intervention of apoptosis.
This knowledge may suggest likely targets for antiviral
development.
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